True Private Wealth Advisors Abbott Laboratories Transaction History

True Private Wealth Advisors

$788 Million
Q1 2025

A detailed history of True Private Wealth Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, True Private Wealth Advisors holds 4,267 shares of ABT stock, worth $548,522. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,267

Previous 4,335 1.57%

Holding current value

$548,522

Previous $490,000 15.51%

% of portfolio

0.07%

Previous 0.06%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$111.1 - $140.22 $7,554 - $9,534	-68 Reduced 1.57%	4,267 $566,000
Q4 2024 Feb 13, 2025	SELL	$111.93 - $119.39 $17,125 - $18,266	-153 Reduced 3.41%	4,335 $490,000
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $7,405 - $8,741	-74 Reduced 1.62%	4,488 $511,000
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $22,764 - $25,411	226 Added 5.21%	4,562 $474,000
Q1 2024 Apr 25, 2024	SELL	$109.52 - $120.96 $183,336 - $202,487	-1,674 Reduced 27.85%	4,336 $492,000
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $74,857 - $91,632	830 Added 16.02%	6,010 $661,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $11,177 - $13,410	-117 Reduced 2.21%	5,180 $501,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $8,364 - $9,320	-83 Reduced 1.54%	5,297 $577,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $1,065 - $1,254	11 Added 0.2%	5,380 $544,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $30,324 - $35,574	-319 Reduced 5.61%	5,369 $589,000
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $580 - $672	6 Added 0.11%	5,688 $550,000
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $20,005 - $24,180	-196 Reduced 3.33%	5,682 $617,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $102,047 - $124,440	-895 Reduced 13.21%	5,878 $680,000
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $1,732 - $2,121	-15 Reduced 0.22%	6,773 $953,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $116,076 - $128,414	-995 Reduced 12.78%	6,788 $801,000
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $93,518 - $110,084	884 Added 12.81%	7,783 $902,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $329,241 - $387,895	3,025 Added 78.08%	6,899 $827,000
Q4 2020 Jan 11, 2021	SELL	$105.0 - $114.42 $107,520 - $117,166	-1,024 Reduced 20.91%	3,874 $424,000
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $39,680 - $48,188	-433 Reduced 8.12%	4,898 $533,000
Q2 2020 Jul 07, 2020	BUY	$76.57 - $98.0 $459 - $588	6 Added 0.11%	5,331 $487,000
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $84,555 - $123,643	-1,346 Reduced 20.18%	5,325 $420,000
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $103,711 - $115,455	1,321 Added 24.69%	6,671 $579,000
Q3 2019 Oct 09, 2019	BUY	$81.84 - $88.74 $163,598 - $177,391	1,999 Added 59.65%	5,350 $447,000
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $24,050 - $28,050	-330 Reduced 8.96%	3,351 $281,000
Q1 2019 Apr 25, 2019	SELL	$66.22 - $80.06 $507,774 - $613,900	-7,668 Reduced 67.57%	3,681 $294,000
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $6,359 - $7,204	-97 Reduced 0.85%	11,349 $820,000
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $6,081 - $7,336	-100 Reduced 0.87%	11,446 $0
Q2 2018 Jul 13, 2018	BUY	$57.57 - $63.54 $48,473 - $53,500	842 Added 7.87%	11,546 $704,000
Q1 2018 Apr 25, 2018	BUY	$56.27 - $63.62 $32,017 - $36,199	569 Added 5.61%	10,704 $641,000
Q4 2017 Jan 19, 2018	BUY	$53.68 - $57.47 $312,095 - $334,130	5,814 Added 134.55%	10,135 $578,000
Q3 2017 Oct 27, 2017	SELL	$48.06 - $53.64 $8,362 - $9,333	-174 Reduced 3.87%	4,321 $230,000
Q2 2017 Aug 07, 2017	BUY	N/A	4,495	4,495 $218,000

Others Institutions Holding ABT

# of Institutions

3,575

Shares Held

1.38B

Call Options Held

9.72M

Put Options Held

8.83M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.

Account

True Private Wealth Advisors Abbott Laboratories Transaction History